CytomX Therapeutics (CTMX) PT Raised to $10 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $10.00 (from $6.50) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
